STN Stock Analysis: Stantec | NYSE
Engineering & Construction | NYSE, USA | Market Cap: 8.051m USD | 12M Return: -35.7% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 36.5M
EPS Trend: 99.2%
Qual. Beats: 0
Rev. Trend: 90.9%
Qual. Beats: 0
Warnings
Tailwinds
No distinct edge detected
Seasonality 10.5 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Stantec Inc. is a Canadian professional services firm that provides engineering, architecture, environmental, and project management services to both public and private clients across Canada, the United States, and international markets. Founded in 1954 and headquartered in Edmonton, the company offers a broad range of capabilities spanning infrastructure planning and design, water resource management, sustainable building solutions, energy and resources consulting, and decommissioning and remediation services. Its client base includes government departments, local authorities, utility companies, and private-sector organizations, with service lines covering transportation, buildings, environmental sciences, geotechnical work, and mechanical, electrical, and plumbing (MEP) engineering.
The company, formerly known as Stanley Technology Group Inc. until its 1998 rebranding, trades on the NYSE under the ticker STN and is classified within the Industrials sector, specifically in the Research & Consulting Services sub-industry. As an engineering and consulting firm, Stantec operates on a project-based, fee-for-service revenue model, which is typical of the professional services industry and often correlates demand with capital expenditure cycles in infrastructure, construction, and environmental remediation.
- US IIJA funding boosts infrastructure consulting backlog
- Water infrastructure demand surges with EPA mandates
- Acquisition pipeline fuels double-digit organic growth target
| Net Income: 454.4m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.08 > 0.02 and ΔFCF/TA 0.30 > 1.0 |
| NWC/Revenue: 9.52% < 20% (prev 9.06%; Δ 0.45% < -1%) |
| CFO/TA 0.09 > 3% & CFO 759.6m > Net Income 454.4m |
| Net Debt (2.96b) to EBITDA (1.05b): 2.84 < 3 |
| Current Ratio: 1.35 > 1.5 & < 3 |
| Outstanding Shares: last quarter (114.1m) vs 12m ago -0.00% < -2% |
| Gross Margin: 40.08% > 18% (prev 42.80%; Δ -2.72% > 0.5%) |
| Asset Turnover: 103.6% > 50% (prev 111.0%; Δ -7.43% > 0%) |
| Interest Coverage Ratio: 6.68 > 6 (EBIT TTM 698.0m / Interest Expense TTM 104.4m) |
| A: 0.09 (Total Current Assets 2.88b - Total Current Liabilities 2.14b) / Total Assets 8.07b |
| B: 0.23 (Retained Earnings 1.83b / Total Assets 8.07b) |
| C: 0.09 (EBIT TTM 698.0m / Avg Total Assets 7.50b) |
| D: 0.72 (Book Value of Equity 3.38b / Total Liabilities 4.68b) |
| Altman-Z'' = 2.73 = A |
| DSRI: 1.10 (Receivables 2.40b/2.16b, Revenue 7.77b/7.70b) |
| GMI: 1.07 (GM 42.80% / 40.08%) |
| AQI: 1.02 (AQ_t 0.53 / AQ_t-1 0.53) |
| SGI: 1.01 (Revenue 7.77b / 7.70b) |
| TATA: -0.04 (NI 454.4m - CFO 759.6m) / TA 8.07b) |
| Beneish M = -2.87 (Cap -4..+1) = A |
As of July 09, 2026, the stock is trading at USD 69.61 with a total of 380,210 shares traded. Over the past week, the price has changed by +1.02%, over one month by -4.99%, over three months by -20.47% and over the past year by -35.68%.
Current recommended Stop Loss: 66.70 (which is 4.2% or 1.3 ATR below the current price).
Stantec has received a consensus analysts rating of 4.18. Therefore, it is recommended to buy STN.
- StrongBuy: 3
- Buy: 7
- Hold: 1
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 94.3 | 35.4% |
Market Cap CAD = 11.4b (8.05b USD * 1.4196 USD.CAD)
P/E Trailing = 23.3709
P/E Forward = 15.4799
P/S = 1.2037
P/B = 3.3598
P/EG = 1.3846
Revenue TTM = 7.77b CAD
EBIT TTM = 698.0m CAD
EBITDA TTM = 1.05b CAD
Long Term Debt = 1.58b CAD (from longTermDebt, last quarter)
Short Term Debt = 390.7m CAD (from shortTermDebt, last quarter)
Debt = 3.32b CAD (from shortLongTermDebtTotal, last quarter) + Leases 727.7m
Net Debt = 2.96b CAD (calculated: Debt 3.32b - CCE 358.6m)
Enterprise Value = 14.4b CAD (11.4b + Debt 3.32b - CCE 358.6m)
Interest Coverage Ratio = 6.68 (Ebit TTM 698.0m / Interest Expense TTM 104.4m)
EV/FCF = 21.09x (Enterprise Value 14.4b / FCF TTM 682.3m)
FCF Yield = 4.74% (FCF TTM 682.3m / Enterprise Value 14.4b)
FCF Margin = 8.78% (FCF TTM 682.3m / Revenue TTM 7.77b)
Net Margin = 5.85% (Net Income TTM 454.4m / Revenue TTM 7.77b)
Gross Margin = 40.08% ((Revenue TTM 7.77b - Cost of Revenue TTM 4.66b) / Revenue TTM)
Gross Margin QoQ = 39.62% (prev 37.31%)
Tobins Q-Ratio = 1.78 (Enterprise Value 14.4b / Total Assets 8.07b)
Interest Expense / Debt = 3.14% (Interest Expense 104.4m / Debt 3.32b)
Taxrate = 24.19% (145.0m / 599.3m)
NOPAT = 529.2m (EBIT 698.0m * (1 - 24.19%))
Current Ratio = 1.35 (Total Current Assets 2.88b / Total Current Liabilities 2.14b)
Debt / Equity = 0.98 (Debt 3.32b / totalStockholderEquity, last quarter 3.38b)
Debt / EBITDA = 2.84 (Net Debt 2.96b / EBITDA 1.05b)
Debt / FCF = 4.34 (Net Debt 2.96b / FCF TTM 682.3m)
Total Stockholder Equity = 3.22b (last 4 quarters mean from totalStockholderEquity)
RoA = 6.06% (Net Income 454.4m / Total Assets 8.07b)
RoE = 14.09% (Net Income TTM 454.4m / Total Stockholder Equity 3.22b)
RoCE = 14.54% (EBIT 698.0m / Capital Employed (Equity 3.22b + L.T.Debt 1.58b))
RoIC = 8.88% (NOPAT 529.2m / Invested Capital 5.96b)
WACC = 6.50% (E(11.4b)/V(14.8b) * Re(7.70%) + D(3.32b)/V(14.8b) * Rd(3.14%) * (1-Tc(0.24)))
Discount Rate = 7.70% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 44.72 | Cagr: 0.53%
[DCF] Terminal Value 77.97% ; FCFF base≈636.0m ; Y1≈729.0m ; Y5≈1.07b
[DCF] Fair Price = 115.6 (EV 16.1b - Net Debt 2.96b = Equity 13.2b / Shares 114.1m; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: 99.20 | EPS CAGR: 17.15% | SUE: 0.43 | # QB: 0
Revenue Correlation: 90.89 | Revenue CAGR: 20.58% | SUE: 0.57 | # QB: 0
EPS current Quarter (2026-06-30): EPS=1.59 | Chg30d=+0.00% | Revisions=-25% | Analysts=10
EPS next Quarter (2026-09-30): EPS=1.81 | Chg30d=+0.00% | Revisions=+36% | Analysts=10
EPS current Year (2026-12-31): EPS=6.20 | Chg30d=+0.00% | Revisions=+62% | GrowthEPS=+17.1% | GrowthRev=+9.3%
EPS next Year (2027-12-31): EPS=6.87 | Chg30d=+0.00% | Revisions=-31% | GrowthEPS=+10.7% | GrowthRev=+6.0%
[Analyst] Revisions Ratio: +12% (up=21, down=16)